Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation volume 42, pages 799–805 (2008)Cite this article

Abstract

Iron overload is common in patients undergoing allogeneic hematopoietic cell transplantation (HCT) for hematologic disorders. Serum ferritin, a marker of tissue iron overload, was measured immediately before transplant in adult patients undergoing myeloablative HCT from matched sibling or unrelated donors. The effect of elevated pretransplant ferritin (defined as ferritin ⩾1000 ng/ml) on day 100 mortality, overall survival, acute GVHD and infectious complications was assessed. Data on 190 patients were analyzed. In univariate analysis, the high-ferritin group had increased day 100 mortality (20 vs 9%, P=0.038), decreased overall survival (log-rank test: P-value=0.004), increased acute GVHD/death (63 vs 43%, P=0.009) and increased incidence of blood stream infections (BSIs)/death (60 vs 44%, P=0.042). In a multivariate analysis, high ferritin was associated with increased risk of death (Cox model: hazard ratio=2.28, P=0.004), increased day 100 mortality (generalized linear model (GLM) odds ratio=3.82, P=0.013), increased incidence of acute GVHD/death (GLM odds ratio=3.11, P=0.001) and increased risk of BSI/death (GLM odds ratio=1.99, P=0.032). The results remained similar when serum ferritin was considered a continuous variable. Elevated serum ferritin adversely impacts on overall survival and increases the likelihood of acute GVHD and BSI after allogeneic HCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Strasser SI, Kowdley KV, Sale GE, McDonald GB . Iron overload in bone marrow transplant recipients. Bone Marrow Transplant 1998; 22: 167–173.

    Article  CAS  PubMed  Google Scholar 

  2. Lucarelli G, Clift RA, Galimberti M, Polchi P, Angelucci E, Baronciani D et al. Marrow transplantation for patients with thalassemia: results in class 3 patients. Blood 1996; 87: 2082–2088.

    CAS  PubMed  Google Scholar 

  3. Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP et al. Prognostic impact of elevated pretransplant serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007; 109: 4586–4588.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Altes A, Remacha AF, Sarda P, Sancho FJ, Sureda A, Martino R et al. Frequent severe iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant 2004; 34: 505–509.

    Article  CAS  PubMed  Google Scholar 

  5. Kontoyiannis DP, Chamilos G, Lewis RE, Giralt S, Cortes J, Raad II et al. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer 2007; 110: 1303–1306.

    Article  PubMed  Google Scholar 

  6. Maertens J, Demuynck H, Verbeken EK, Zachee P, Verhoef GEG, Vandenberghe P et al. Mucormycosis in allogeneic bone marrow transplant recipients: report of 5 cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 1999; 24: 307.

    Article  CAS  PubMed  Google Scholar 

  7. Kamble RT, Selby GB, Mims M, Kharfan-Dabaja MA, Ozer H, George JN . Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 506–510.

    Article  CAS  PubMed  Google Scholar 

  8. Morado M, Ojeda E, Garcia-Bustos J, Aguado MJ, Arrieta R, Quevedo E et al. BMT: serum ferritin as risk factor for veno-occlusive disease of the liver. Prospective cohort study. Hematology 2000; 4: 505–512.

    Article  CAS  PubMed  Google Scholar 

  9. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  10. Armand P, Kim HT, Cutler C, Ho VT, Koreth J, Ritz J et al. A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2008; 14: 28–35.

    Article  CAS  PubMed  Google Scholar 

  11. Altes A, Remacha AF, Sureda A, Martino R, Briones J, Canals C et al. Iron overload might increase transplant-related mortality in hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 987–989.

    Article  CAS  PubMed  Google Scholar 

  12. Bullen JJ, Rogers HJ, Spadling PB, Ward CG . Natural resistance, iron and infection: a challenge for clinical medicine. J Med Microbiol 2006; 55: 251–258.

    Article  CAS  PubMed  Google Scholar 

  13. Khan FA, Fisher MA, Khakoo RA . Association of hemochromatosis with infectious diseases. Int J Infect Dis 2007; 11: 482–487.

    Article  CAS  PubMed  Google Scholar 

  14. Altes A, Remacha AF, Sarda P, Baiget M, Sureda A, Martino R et al. Early clinical impact of iron overload in stem cell transplantation. A prospective study. Ann Hematol 2007; 86: 443–447.

    Article  PubMed  Google Scholar 

  15. Miceli MH, Dong L, Grazziutti ML, Fassas A, Thertulien R, Van Rhee F et al. Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients. Bone Marrow Transplant 2006; 37: 857–864.

    Article  CAS  PubMed  Google Scholar 

  16. Evens AM, Mehta J, Gordon LI . Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress. Bone Marrow Transplant 2004; 34: 561–571.

    Article  CAS  PubMed  Google Scholar 

  17. Jastaniah W, Harmatz P, Pakbaz Z, Fischer R, Vichinsky E, Walters MC . Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies. Pediatr Blood Cancer 2008; 50: 319–324.

    Article  PubMed  Google Scholar 

  18. Wood JC . Diagnosis and management of transfusion iron overload: the role of imaging. Am J Hematol 2007; 82: 1132–1135.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sahlstedt L, Ebeling F, Bonsdorff L, Parkinnen J, Ruutu T . Non-transferrin-bound iron during allogeneic stem cell transplantation. Br J Hematol 2001; 113: 836–838.

    Article  CAS  Google Scholar 

  20. Bradley SJ, Gosriwitana I, Srichairatanakool S, Hider RC, Porter JB . Non-transferrin-bound iron induced by myeloablative chemotherapy. Br J Hematol 1997; 99: 337–343.

    Article  CAS  Google Scholar 

  21. Carmine TC, Evans P, Bruchelt G, Evans R, Handgretinger R, Niethammer D et al. Presence of iron catalytic for free radical reactions in patients undergoing chemotherapy: implications for therapeutic management. Cancer Lett 1995; 94: 219–226.

    Article  CAS  PubMed  Google Scholar 

  22. Cortelezzi A, Cattaneo C, Cristiani S, Duca L, Sarina B, Deliliers GL et al. Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis. Hematol J 2000; 1: 153–158.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA

    V Pullarkat, K Patane & S J Forman

  2. Division of Information Sciences, Department of Biostatistics, City of Hope National Medical Center, Duarte, CA, USA

    S Blanchard & A Dagis

  3. Division of Infectious Diseases, City of Hope National Medical Center, Duarte, CA, USA

    B Tegtmeier & J Ito

Authors
  1. V Pullarkat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Blanchard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B Tegtmeier
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Dagis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K Patane
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S J Forman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V Pullarkat.

Additional information

Presented in part at the 49th annual meeting of the American Society of Hematology, 8–11 December, Atlanta, GA, USA.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pullarkat, V., Blanchard, S., Tegtmeier, B. et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 42, 799–805 (2008). https://doi.org/10.1038/bmt.2008.262

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.262

Keywords

This article is cited by

Search

Advanced search

Quick links